Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Development And Validation Of A Prediction Model For Gastric Cancer: A Single-center Prospective Study.
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Development And Validation Of A Prediction Model For Gastric Cancer: A Single-center Prospective Study.

Related Experiment Video

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

980

Development and validation of a prediction model for gastric cancer: a single-center prospective study.

Suyu Sun1, Feifei Huang2, Xueqin Xu3

  • 1Department of Obstetrics and Gynecology, Wenzhou Central Hospital, Wenzhou, China.

Laboratory Medicine
|October 11, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

A new diagnostic nomogram for gastric cancer (GC) was developed using 5 key parameters. This tool demonstrates high accuracy in distinguishing GC from benign conditions, offering clinical utility.

Keywords:
SPRR2Acarbohydrate antigen 125carbohydrate antigen 199carcinoembryonic antigen

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.1K

Related Experiment Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

980
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Published on: July 19, 2019

10.1K

Area of Science:

  • Oncology
  • Medical Diagnostics
  • Biostatistics

Background:

  • Gastric cancer (GC) remains a significant global health challenge.
  • Accurate and early diagnosis is crucial for effective treatment and improved patient outcomes.
  • Existing diagnostic methods may have limitations in sensitivity and specificity.

Purpose of the Study:

  • To develop and validate a novel nomogram for the diagnosis of gastric cancer (GC).
  • To identify key clinical and analytical parameters predictive of GC.
  • To assess the diagnostic performance of the developed nomogram.

Main Methods:

  • Prospective analysis of 146 patients categorized into GC and benign lesion groups.
  • Data split into training (70%) and internal validation (30%) sets.
gastric cancer
model
  • Logistic regression analysis for parameter selection and model development.
  • Evaluation using receiver operating characteristic (ROC) curves, calibration, and decision curve analysis.

    • Main Results:

    • Five parameters were identified: albumin, carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), creatinine, and small proline-rich protein 2A (SPRR2A).
    • The nomogram achieved an area under the curve (AUC) of 0.968 in the training set and 0.979 in the internal validation set.
    • Demonstrated strong diagnostic performance in distinguishing GC from benign lesions.

    Conclusions:

    • A novel, validated nomogram for GC diagnosis has been developed.
    • The nomogram incorporates five significant predictive parameters.
    • The model exhibits excellent diagnostic accuracy and holds potential for clinical application in differentiating GC.